DOCSLIB.ORG

SPECT, MRI and Cognitive Functions in Multiple Sclerosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
SPECT, MRI and Cognitive Functions in Multiple Sclerosis 110 Journal ofNeurology, Neurosurgery, and Psychiatry 1991;54:110-115 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.54.2.110 on 1 February 1991. Downloaded from SPECT, MRI and cognitive functions in multiple sclerosis Carlo Pozzilli, Domenico Passafiume, Silvia Bemardi, Patrizia Pantano, Chiara Incoccia, Stefano Bastianello, Luigi Bozzao, Gian Luigi Lenzi, Cesare Fieschi Abstract in the study of cognitive deficit associated Seventeen patients with relapsing remit- with Alzheimer's dementia.2"22 ting multiple sclerosis (MS) and mild The aim of this study was to examine the physical disability had neuropsycho- regional distribution of 99mTc HMPAO in logical testing, magnetic resonance the brain, the extent of cerebral lesions by imaging (MRI) and single photon MRI and their relationship to neuropsycho- emission computerised tomography logical findings in MS. Our study specifically (SPECT) using technetium 99m (99mTc) addresses the relapsing-remitting MS type hexamethyl-propyleneamine oxime with relatively mild physical and cognitive (HMPAO). Performance in verbal disturbance. fluency, naming and memory testing appeared to be impaired in MS patients compared with 17 age-sex and education Materials and methods matched normal controls. Patients Weighted periventricular and con- Seventeen right handed MS patients (12 fluent lesion scores and the width of the women and five men), mean (SD) age 31 (10) third ventricle, proved to be the most years and educational level 14 (3 5) years were sensitive MRI measures in differentiat- selected from those admitted to our MS out- ing more cognitively impaired patients patient clinic. The patients were evaluated from those who were relatively unim- according to the Schumacher criteria as paired. having clinically definite MS.23 The diagnosis Ratios of regional to whole brain was further supported by evoked potentials activity, measured by SPECT, showed and CSF studies. All patients had a relapsing- significant reduction in the frontal lobes remitting form of MS24 and they were studied and in the left temporal lobe of MS during a stationary phase. At least three patients. A relationship was found be- months elapsed between the occurrence of an tween left temporal abnormality in exacerbation or the termination of therapy 99mTc-HMPAO uptake and deficit in (steroids/corticotropin) and testing. verbal fluency and verbal memory. Excluded from the study were any patients http://jnnp.bmj.com/ Finally, asymmetrical lobar activity who did not meet the criteria of definite MS University of Rome, or Department of indicated a predominant left rather than whose disease course was chronic-progres- Neurological Science right temporo-parietal involvement. sive. Patients with EDSS score >4 or those C Pozzilli with Mini Mental State Examination S Bernardi P Pantano (MMSE) lower than 23 were also excluded. S Bastianello A substantial proportion of patients with mul- Mean (SD) clinical disease duration was L Bozzao tiple sclerosis (MS) show disturbance of eight (five) years, mean degree of impairment G Lenzi higher cognitive functions.'` Cognitive as estimated by the Kurtzke Expanded Dis- on September 29, 2021 by guest. Protected copyright. C Fieschi decline is more frequent at the more advanced ability Status Scale (EDSS)2" was 1-7 (1 0) Department of stage of the disease6 and in Psychology chronic progres- and mean MMSE was 28-5 (1-7). C Incoccia sive MS.7 It may, however, also be present in University of the early phase89 and in patients with mild Neuropsychological assessment L'Aquila, Rome, Italy physical disability.'°0 The extent of cognitive The neuropsychological test battery26 consis- Department of impairment is related to cerebral ventricular ted of measures Environmental of general intelligence, lan- Science size"2 corpus callosum atrophy'3 14 and degree guage, memory, attention and visuospatial D Passafiume of cerebral lesions quantified by magnetic abilities lasting approximately two hours. The Presented as an abstract at resonance imaging (MRI).1'58 battery was composed of the following tests: the 14th International Previous work using positron emission General intelligence Coloured Symposium on Cerebral Progressive Blood Flow and Metabolism, tomography (PET) has demonstrated a Matrices. This test was administered follow- "Brain 89", Bologna, 28th generalised coupled reduction in both cerebral ing the standard procedure to provide an May-Ist June 1989 oxygen utilisation and blood flow in MS estimate of non verbal general Correspondence to: intelligence. Dr Pozzilli, Department of patients. The reduction was found in both Abstract/conceptual reasoning Wisconsin Neurological Science, white and grey matter and correlated with University of Rome, Viale Sorting Card Test. This was administered dell'Universita 30, 00185 cognitive impairment, rather than with following the standard procedure. The Rome, Italy. locomotor disability or clinical disease number of perseverative errors were recorded Received 11 December 1989 duration.'9 Recently, single photon emission as a and in revised form measure of abstracting ability. 18 April 1990. computed tomography (SPECT) has given Language Boston Naming Test.27 In this test Accepted 15 May 1990 information similar to that provided by PET of confrontational naming ability, subjects SPECT, MRI and cognitivefunctions in multiple sclerosis illl were shown line drawings, one at a time, of 60 radiologist (LB) blind to the clinical and J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.54.2.110 on 1 February 1991. Downloaded from objects that varied in familiarity. The total neuropsychological findings. number of correct responses serves as the Lesions were divided into two categories: score. single lesions and confluent lesions. Single Set test. This is a verbal fluency test, based lesions were defined as rounded areas of on the number of components in a given abnormal high signal intensity. Confluent category that the subject can denominate in lesions have an appearance of more than one 120s. We adopted the categories "furniture" rounded single lesion having come together to and "birds". Scoring is the mean of names form an irregularly shaped "lump" or thick produced in the two categories. (> 5 mm) linear area abnormality.28 Visuospatial abilities Street Completion Weighted lesion scores were developed Test. This is a test of "speed of closure". We based on the number and size of lesions. We adopted the 11 items version. Each item is assigned the following weights according to composed by an incomplete black figure of lesion size: 1 = < 8 mm; 2 = 8-20 mm; a common object that has to be identified. 3 = >20 mm. Scoring is on pass/fail basis. Lesions which were periventricular in part Elithorn's Perceptual Maze Test. This is and extended out into the brain parenchyma composed of an 18 lattice type maze and the were considered "periventricular", while subject has to trace a line from bottom to top lesions which were apparently separate from of the maze, through the maximum number of the ventricles were designated "discrete" black points randomly placed on the net cerebral lesions.29 This latter group included figure. The scoring is on time and number of both "pure" white matter lesions and those black point basis. located just beneath the cortical surface (grey- Verbal memory Digit Span. We administered white matter junctions). and scored this subtest of WAIS following The evaluation of the corpus callosum (CC) standard instructions. was carried out on sagittal TI weighted Rey Auditory Verbal Learning. A list of 15 images. To obtain area measurements of CC stimulus-name of common objects is read five and cerebral hemisphere, the outlines of these times by the examiner to the subject. After structures were traced on a monitor screen each presentation the subject has to repeat as with a cursor and their areas were then cal- many words as he/she can recall. We assigned culated by a means of a computerised graphic two different scores. Short term memory table. The CC/brain area ratio was calculated scores: number of words recalled after the and then analysed."' first presentation; Long term memory scores: Finally, linear measurements were recorded the words correctly reported after a 15 min- including: (1) Frontal Horn Index, the ratio utes delay. of the maximal distance between the lateral Visuospatial memory Corsi Tapping Test. border of the frontal horns and the maximal The subject is presented with nine blocks width of the outer skull table at the same level; impartially arranged on a board. The exam- (2) Cella Media Index, the ratio of the mini- iner taps the blocks, and the subject is mal width of the lateral ventricles at the cella required to tap the same blocks in exactly the media level to outer skull table at the same same pattern. Scoring is the longest sequence level; (3) Third Ventricular Index, the ratio of of blocks correctly tapped. the maximal width of the third ventricle and http://jnnp.bmj.com/ Rey Osterreith Complex Figure. The width of outer skull at the same level. subject is presented with a complex geo- metrical drawing that he/she has to reproduce SPECT first by copying and after 15 minutes from SPECT brain imaging was performed with a memory. Scores are the number of element rotating gamma camera (GE 400 T) connected correctly reproduced and placed. to a dedicated computer (HP 1000, Eurobit). Seventeen normal controls (NC) matched Twenty mCi of 99mTc HMPAO was injec- on September 29, 2021 by guest. Protected copyright. one to one with the patients in terms of age, ted into an antecubital vein with the patient sex and education level, were recruited from sitting quietly in a softly lit room. After 10 the community. Normal controls were people minutes, patients were placed supine using a from the hospital staff without a history of head holder to minimise motion. Acquisitions central nervous system disease or alcohol were made recording 64 angular views using a abuse. Normal controls were evaluated using 64 x 64 matrix format. In 30 minutes four the same neuropsychological procedures as million total counts were collected.
Load more

Recommended publications
  • Updated Criteria for Diagnosing Multiple Sclerosis
    r e v i e w a r t i c l e Updated criteria for diagnosing Multiple Sclerosis or in the case of progressive MS, a slow or step- Key take home messages wise progression of disability over a period of • The diagnostic criteria for MS have at least six months been recently updated • and objective clinical evidence of lesions in • These criteria should only be applied two or more distinct sites in the white matter to populations in whom MS is of the central nervous system common and patients who present • with no more satisfactory explanation. Peter Brex with typical symptoms for which no The Schumacher criteria were purely clinical, MB BS, MD, FRCP is a Consultant Neurologist at King’s College Hospital better explanation can be found although investigations were encouraged (blood, NHS Foundation Trust. He trained in • All patients with suspected MS should urine, chest X-ray, CSF analysis) to exclude London and was appointed to his current have an MRI brain scan; spinal cord alternative conditions. role in 2005. He specialises in multiple imaging is not mandatory Over the next few years modifications to the sclerosis, with a particular interest in early 2,3 prognostic markers and the management • Unmatched oligoclonal bands in the Schumacher criteria were published but in 1983 of MS during pregnancy. CSF can be used as a substitute for the Schumacher criteria were replaced by criteria demonstrating dissemination in time, developed by a committee chaired by Charles allowing an earlier diagnosis than was Poser (1923 – 2010).4 The Poser criteria incorpor- previously possible ated laboratory and clinical tests developed in the previous decade to support the diagnosis with ‘paraclinical evidence’ of lesions.
    [Show full text]
  • And Multiple Sclerosis Particular Problem, I Wish to Make the Follow
    524 Maters arising prolong the lives of those suffering, thereby Most of these problems are not taken into 6 Poser C, Paty D, Scheinberg L, et al. New J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.55.6.524-b on 1 June 1992. Downloaded from providing the necessity for self-action by the consideration in Sibley's article. diagnostic criteria for multiple sclerosis. Ann patient. It is germane to point out that the "scien- Neurol 1983;13:227-31. Perhaps when we advise patients and tific" evidence of epidemiology and biostatis- families who face difficult decisions, we tics overlooks the fact that such studies can at Sibley et al reply: would be better to heed the available evi- best only be estimates within a cohort and dence about who will do well and who will do cannot be generalised; epidemiological stud- We age- and sex-matched MS patients with badly rather than withholding recommenda- ies are most useful in providing aetiological healthy controls solely to establish the degree tions because unduly cautious statisticians clues but cannot be used to deny possible of accident-proneness of MS patients. It choose to neglect the downside effects of causal relationships.2 As was pointed out by probably needs to be clearly restated that the their theoretical arguments. Neurologists are Schoenberg, "Statistical significance (or lack patients were used as their own controls in an especially favourable position to under- thereof) does not equal biological when they were not "at risk". stand the misery that accompanies chronic, significance". Physical trauma had no positive influence overwhelming brain damage.
    [Show full text]
  • (Pre-Allison & Millar) Ipsen Criteria: 1939-48, Boston, MA
    Early criteria (pre-Allison & Millar) Ipsen criteria: 1939-48, Boston, MA USA1 - Probable MS o Those cases with records presenting convincing evidence - Possible MS o Those cases whose evidence was more doubtful. Ipsen acknowledges these allocations are fairly arbitrary but also notes that absolutely certainty of diagnosis is impossible except by autopsy, a limitation we are similarly affected by even today. Westlund & Kurland: 1951, Winnipeg, MT Canada & New Orleans, LA USA2 Diagnostic groupings as follows, with no explicit requirements for each, rather deferring to the discretion of the examining neurologist: - Certain MS - Probable MS - Possible MS o In this class, the changes for and against MS were considered approximately even - Doubtful, unlikely or definitely-not MS2 Sutherland criteria: 1954, Northern Scotland3 - Probable MS o This category for patients in whom the history, the results of clinical examination and, where available, hospital investigations, indicated that the diagnosis of MS was beyond reasonable doubt. - Possible MS o Patients in whom a diagnosis of MS appears justifiable but in which the diagnosis could not be established beyond reasonable doubt; o This group also included patients who did not wish to be examined or could not be seen – review of hospital records for these patients suggested a diagnosis of MS - Rejected cases o Patients found to be suffering from a disease other than MS Allison & Millar Criteria and variants Allison & Millar criteria: 1954, Northern Ireland4 - Early disseminated sclerosis: 1) this category for patients with little in the way of symptomatic presentation but with a recent history consistent with disease onset, i.e. optic neuritis, ophthalmoplegia (double vision), vertigo, sensory problems like pins & needles or numbness, or motor problems like weakness.
    [Show full text]
  • Nayakphd2018.Pdf
    This work is protected by copyright and other intellectual property rights and duplication or sale of all or part is not permitted, except that material may be duplicated by you for research, private study, criticism/review or educational purposes. Electronic or print copies are for your own personal, non- commercial use and shall not be passed to any other individual. No quotation may be published without proper acknowledgement. For any other use, or to quote extensively from the work, permission must be obtained from the copyright holder/s. 1 2 3 Structure and function of the visual pathway in demyelinating optic neuropathy Devaki Nayak Thesis submitted for degree of PhD June 2018 Keele University 4 Acknowledgments I take this opportunity to thank Professor Hawkins for all the help and advice that he provided me over the entire duration of work. I would like to thank the team at Keele Multiple Sclerosis Research Group for their help, friendship and humor throughout the period of research. I once again thank Professor Hawkins for guiding an Ophthalmologist to explore the world of MS in Neurology. I would like to thank Professor Peter Jones for his valuable input on statistical methodology and Professor Richard Strange for his weekly input on statistics from the very first recruitment into this project. I specially want to thank Dr. Ramachandran who spent considerable amount of time in guiding the project and helping with meetings with Professor Jones. I am also thankful to Janice Guildford who helped me with knowledge of existent database in the Keele Multiple Sclerosis Research Group.
    [Show full text]
  • Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis a Consensus Statement
    NEUROLOGICAL REVIEW Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis A Consensus Statement Mark S. Freedman, MSc, MD, FRCPC; Edward J. Thompson, DSc; Florian Deisenhammer, MD; Gavin Giovannoni, PhD; Guy Grimsley, PhD; Geoffrey Keir, PhD; Sten Öhman, PhD; Michael K. Racke, MD; Mohammad Sharief, PhD; Christian J. M. Sindic, MD, PhD; Finn Sellebjerg, MD, PhD, DMSci; Wallace W. Tourtellotte, MD, PhD ew criteria for the diagnosis of multiple sclerosis (MS) were published as the result of an internationally formed committee. To increase the specificity of diagnosis and to minimize the number of false diagnoses, the committee recommended the use of both clinical and paraclinical criteria, the latter involving information obtained from Nmagnetic resonance imaging, evoked potentials, and cerebrospinal fluid (CSF) analysis. Although rigorous magnetic resonance imaging requirements were provided, the “new criteria paper” fell short in terms of guidelines as to how the CSF analysis should be performed and simply equated the IgG index with isoelectric focusing, without any justification. The spectrum of parameters ana- lyzed and methods for CSF analysis differ worldwide and often yield variable results in terms of sensitivity, specificity, accuracy, and reliability, with no decided “optimal” CSF test for the diag- nosis of MS. To address this question specifically, an international panel of experts in MS and CSF diagnostic techniques was convened and the result was this article, representing a consensus of all the participants. These recommendations for establishing a standard for the evaluation of CSF in patients suspected of having MS should greatly complement the new criteria in ensuring that a correct diagnosis of MS is being made.
    [Show full text]
  • New Diagnostic Criteria for Multiple Sclerosis: Guidelines for Research Protocols
    SPECIAL ARTICLE New Diagnostic Criteria for Multiple Sclerosis: Guidelines for Research Protocols Charles M. Poser, MD,l Donald W. Paty, MD,’ Labe Scheinberg, MD,3 W. Ian McDonald, FRCP,4 Floyd A. Davis, MD,’ George C. Ebers, MD,‘ Kenneth P. Johnson, MD,’ William A. Sibley, MD,8 Donald H. Silberberg, MD,9 and Wallace W. Tourtellotte, MD” Several schemes for the diagnosis and clinical clas- Method and Procedure sification of multiple sclerosis (MS) have been ad- On April 26 and 27, 1982, the following persons participated vanced [l}. The best known is that published by in a Workshop on the Diagnosis of Multiple Sclerosis, held in Schumacher et alC31. The criteria for this scheme were Washington, DC, for the purpose of establishing new diag- established in order to select patients for participation nostic criteria for MS: Bruce Becker (National Naval Medical in therapeutic trials, and pertain only to what might be Center),Jerry Blaivas (Columbia), Keith Chiappa (Harvard), called definite MS. No provision was made for incor- Floyd Davis (Rush), Burton Drayer (Duke), George Ebers porating supportive laboratory data into the diagnostic (Western Ontario), Andrew Eism (British Columbia), criteria. Robert Herndon (Rochester, NY), Kenneth Johnson (Mary- As no reliable specific laboratory test for the diag- land), Ian McDonald (National Hospital, London), Dale nosis of MS has been discovered, the diagnosis remains McFarlin (NINCDS), Donald Paty, Co-chairman (British a clinical one, and there is still a need for clinical diag- Columbia),Janis Peyser
    [Show full text]
  • Swedish Neuroscience Institute
    Diagnosing MS MS can be difficult to diagnose. There is no test that is 100% certain in identifying who has the disease and who does not have the disease. This has led to the development of several sets of diagnostic criteria over the years. One of the first sets of criteria was known as the Schumacher criteria. These criteria required dissemination in both space and time, meaning that patients had to have more than one part of the nervous system involved (dissemination in space) at more than one time (dissemination in time). Dissemination is space and time is still a cornerstone of the diagnosis. The Schumacher criteria were followed by the Poser Criteria which included testing for spinal fluid and recognized degrees of certainty with the diagnosis. The best and most current set of criteria for diagnosing MS is the McDonald criteria. These were first developed in 2001 by an international panel in association with the National MS Society. The McDonald criteria were revised in 2005 and again in 2010. The 2010 revision to the McDonald criteria is the current standard for diagnosis. Overview The primary goal of the McDonald Criteria is to enable the diagnosis of MS sooner and to permit earlier treatment of MS. For clinical research trials it is important to ensure that those without a definite diagnosis of MS are not enrolled. The bottom line is that there have to be 2 attacks in time and at 2 locations. You can get the locations in time either by clinical attacks or by MRI changes over time.
    [Show full text]
  • MS Misdiagnosis— an Analysis from Case Studies
    6/6/2011 MS Misdiagnosis— An Analysis From Case Studies Joseph R. Berger, MD Ruth L. Works Professor and Chairman Department of Neurology University of Kentucky College of Medicine Chief of Department and Head of MS Center University of Kentucky Medical Center Lexington, Kentucky Disclosures Sources of Funding for Research: Bayer HealthCare Pharmaceuticals; Biogen Idec; EMD Serono, Inc. Consulting Agreements: Bayer HealthCare Pharmaceuticals; Biogen Idec; Genentech, Inc.; GlaxoSmithKline; Millennium Pharmaceuticals,,; Inc.; Perseid Other support: Bayer HealthCare Pharmaceuticals; Biogen Idec; Serono, Inc. Financial Interests/Stock Ownership: None Discussion of Off-Label, Investigational, or Experimental Drug Use: Cyclophosphamide, intravenous immunoglobulins A handful of patience is worth more than a barrel full of brains. Dutch Proverb 1 6/6/2011 Causes of Misdiagnosis • Diagnosis momentum • Diagnosis even on insufficient evidence becomes fixed in a doctor’s mind • Framing effects • Being swayed by subtle wording or focusing on certain aspects of a case more than others • Satisfaction of search • Stopping when you find a satisfying diagnosis • Confirmation bias (anchoring) • Dismissing material that does not fit with your diagnostic impression • Attribution error • Failing to consider a diagnosis that does not fit the prototype • Representativeness error • Failing to consider possibilities that contradict the prototype and base rate of disease • Failing to account for base rates (“If you hear hoof beats, think horses, not zebras”) •
    [Show full text]
  • Magnetization Transfer Imaging to Investigate Tissue Structure and Optimise Detection of Blood Brain Barrier Leakage in Multiple Sclerosis
    Magnetization Transfer Imaging to Investigate Tissue Structure and Optimise Detection of Blood Brain Barrier Leakage in Multiple Sclerosis Dr Nicholas Charles Silver, MBBS; MRCP A thesis submitted to the University of London for the degree of Doctor of Philosophy March 2001 NMR Research Unit Institute of Neurology University College London Queen Square London WCIN 3BG United Kingdom ProQuest Number: U643048 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest U643048 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 Abstract Magnetic resonance imaging (MRI) has become a powerful researeh tool for in vivo evaluation and monitoring of multiple sclerosis (MS). Conventional MRI techniques detect changes in the density or relaxation characteristies of “free” water protons. They are sensitive but lack pathological specificity. Magnetization transfer (MX) imaging provides a method for evaluating those protons “bound” to maeromolecular struetures. Part one of this thesis outlines the clinical and pathological features of MS and discusses the importance of demyelination and blood-brain barrier breakdown. An introduction to MRI and MX imaging techniques is provided.
    [Show full text]
  • Multiple Sclerosis Disease Modifying Therapies Update
    Practical Controversies in MS Lucas McCarthy, MD, MSc Neurologist, Director MS Center Practical Controversies How to approach common questions in the gray-zone of evidence- based practice? © 2016 Virginia Mason Medical Center The Evidence Free Zone © 2016 Virginia Mason Medical Center Practical Controversies in MS • Misdiagnosis of MS • Vitamin D testing / supplementation • Use of complimentary / experimental treatments • Treatment of Progressive MS © 2016 Virginia Mason Medical Center Poll Everywhere – Audience Participation Open cell phone or laptop to following link to participate in live questions https://pollev.com/MSsummit © 2016 Virginia Mason Medical Center Misdiagnosis of Multiple Sclerosis Misdiagnosis of MS Updated 2017 McDonald MS Diagnostic Criteria Easier to diagnosis = Easier to misdiagnose? © 2016 Virginia Mason Medical Center MS Diagnosis – 2017 Updated Criteria Lesions: ≥ 2 characteristic lesions (>3mm) in ≥ 2 different locations Symptoms: objective clinical evidence of at least 1 lesion Relapse: ≥ 1 characteristic clinical attack Changes over Time: ≥2 CSF Oligoclonal bands or >1 attack over time or new lesions over time (including enhancing and non-enhancing) *No other reasonable diagnosis © 2016 Virginia Mason Medical Center MS Diagnosis – Evolving Diagnostic Criteria MS Diagnostic Criteria Comments 1965 - Schumacher Criteria 2 attacks of neurologic symptoms > 24 hours in duration, separated by at least one month. No MRI yet 1983 - Poser Criteria Added cerebrospinal fluid (CSF) markers and Evoked Potentials to diagnostic
    [Show full text]
  • Prevalence of Multiple Sclerosis in Al Quseir City, Red Sea Governorate, Egypt
    Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Year: 2016 Volume: 12 Neuropsychiatric Disease and Treatment Dovepress Running head verso: El-Tallawy et al Running head recto: Epidemiology of multiple sclerosis in Egypt open access to scientific and medical research DOI: http://dx.doi.org/10.2147/NDT.S87348 Open Access Full Text Article ORIGINAL RESEARCH Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt Hamdy N El-Tallawy1 Background: Multiple sclerosis (MS) is a chronic and disabling disorder with considerable Wafaa M A Farghaly1 social effects and economic sequelae. It is one of the major causes of disability in young Reda Badry1 adults. Nabil A Metwally2 Objectives: This study aimed at detecting the prevalence of MS among the population of Ghaydaa A Shehata1 Al Quseir city. Tarek A Rageh1 Methods: This study is a part of door-to-door survey of major neurological disorders that was conducted in Al Quseir city, Red Sea Governorate, Egypt. The sample size was 33,285 persons. Mohamed Abd El Hamed1 The youngest patient was 17 years old. The number of people at and above 17 years of age Mahmoud R Kandil1 was 21,827. They were screened by three neurologists. Then, the positive cases were subjected 1Department of Neurology and to meticulous clinical evaluation by three staff members of Department of Neurology, Assiut Psychiatry, Assiut University Hospital, Assiut, Egypt; 2Department of University Hospital, Egypt. Essential investigations were done. For personal use only. Neurology and Psychiatry, Al Azhar Results: A total of three cases of MS were diagnosed with an age-specific prevalence $17 University Hospital, Assiut Branch, years of 13.7/100,000.
    [Show full text]
  • The Diagnosis of Multiple Sclerosis
    TheThe DiagnosisDiagnosis OfOf MultipleMultiple SclerosisSclerosis DRDR SAHERSAHER HASHEMHASHEM PROFPROF OFOF NEUROLOGYNEUROLOGY CAIROCAIRO UNIVERSITYUNIVERSITY ThereThere isis nono pathpath gnomonicgnomonic oror perfectperfect laboratorylaboratory testtest whichwhich maymay bebe usedused inin isolationisolation toto reliablyreliably diagnosediagnose MS.MS. TheThe keykey toto correctcorrect diagnosisdiagnosis isis typicalitytypicality TheThe duckduck testtest isis importantimportant ,, (( isis thisthis aa duck,duck, itit lookslooks likelike aa duck,duck, walkwalk likelike andand quacksquacks likelike aa duck,duck, thenthen itit isis probablyprobably aa duck.duck. duck, and QuestionQuestion OneOne WhatWhat isis thethe mostmost commoncommon mistakemistake duringduring MSMS diagnosis?diagnosis? TheThe mostmost commoncommon mistakemistake duringduring MSMS diagnosisdiagnosis isis aa falsefalse positivepositive attributionattribution thatthat isis makingmaking aa diagnosisdiagnosis ofof MSMS inin patientspatients whowho dondon ’’tt havehave MS.OftenMS.Often thisthis errorerror isis thethe resultresult ofof uncriticaluncritical oror causalcausal reliancereliance onon MRIMRI withoutwithout appropriateappropriate clinicalclinical correlationcorrelation 6262 patientspatients assessedassessed byby generalgeneral neurologistsneurologists andand reassessedreassessed byby otherother generalgeneral neurologistsneurologists usingusing McMc DonaldDonald ’’ss criteriacriteria andand foundfound 51%51% ofof MSMS patientspatients werewere notnot confirmed.confirmed.
    [Show full text]